Trials for the new migraine drug, Tezampanel (NGX424), are moving quickly ahead. So it’s time to catch up on what this drug is, and who it might help. Tezampanel is based on an emerging understanding of the role of glutamate (an amino acid) in pain. Targeting glutamate receptors (either through antagonists like Tezampanel or through [...]
{ 7 comments }
Loading ...
